世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039079

神経変性疾患治療薬の世界市場(2024-2028)

TechNavio

Global neurodegenerative diseases therapeutics market 2024-2028

発刊日 2024/06/13

言語英語

体裁PDF/155ページ

ライセンス/価格155ページ

0000039079

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

神経変性疾患治療薬市場は2023年から2028年に212億9000万米ドル、予測期間中のCAGRは8.51%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、強力な医薬品開発パイプライン、神経変性疾患に関する多額の研究資金、および高感度の診断手段の利用可能性によって推進されています。

調査範囲

  • 市場セグメント
    ➣ 適応症別
      ◇ 多発性硬化症
      ◇ アルツハイマー病
      ◇ パーキンソン病
      ◇ ハンチントン病
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、高齢化人口の増加が、今後数年間の神経変性疾患治療薬市場の成長を促進する主な理由の1つであると特定しています。また、神経変性疾患の遺伝的根拠と分子病理の理解の向上と高い経済的負担により、市場でかなりの需要が生まれるでしょう。

神経変性疾患治療薬市場に関するレポートは、次の分野をカバーしています。

  • 神経変性疾患治療薬市場の規模
  • 神経変性疾患治療薬市場の予測
  • 神経変性疾患治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AB Science SA
    ➣ AbbVie Inc.
    ➣ Acadia Pharmaceuticals Inc.
    ➣ Biogen Inc.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ H Lundbeck AS
    ➣ 三菱ケミカル(Mitsubishi Chemical Corp.)
    ➣ Novartis AG
    ➣ Sanofi SA
    ➣ Teva Pharmaceutical Industries Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Indication
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Neurodegenerative Diseases Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2018 - 2022 ($ million)
4.2 Indication segment analysis 2018 - 2022
Historic Market Size - Indication Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Indication
6.1 Market segments
Chart on Indication - Market share 2023-2028 (%)
Data Table on Indication - Market share 2023-2028 (%)
6.2 Comparison by Indication
Chart on Comparison by Indication
Data Table on Comparison by Indication
6.3 Multiple sclerosis - Market size and forecast 2023-2028
Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
6.4 Alzheimers disease - Market size and forecast 2023-2028
Chart on Alzheimers disease - Market size and forecast 2023-2028 ($ million)
Data Table on Alzheimers disease - Market size and forecast 2023-2028 ($ million)
Chart on Alzheimers disease - Year-over-year growth 2023-2028 (%)
Data Table on Alzheimers disease - Year-over-year growth 2023-2028 (%)
6.5 Parkinsons disease - Market size and forecast 2023-2028
Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
6.6 Huntingtons disease - Market size and forecast 2023-2028
Chart on Huntingtons disease - Market size and forecast 2023-2028 ($ million)
Data Table on Huntingtons disease - Market size and forecast 2023-2028 ($ million)
Chart on Huntingtons disease - Year-over-year growth 2023-2028 (%)
Data Table on Huntingtons disease - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Indication
Market opportunity by Indication ($ million)
Data Table on Market opportunity by Indication ($ million)

7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.12 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.13 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business

11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 AB Science SA
AB Science SA - Overview
AB Science SA - Product / Service
AB Science SA - Key offerings
11.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
11.5 Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. - Overview
Acadia Pharmaceuticals Inc. - Product / Service
Acadia Pharmaceuticals Inc. - Key offerings
11.6 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
11.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.8 H Lundbeck AS
H Lundbeck AS - Overview
H Lundbeck AS - Product / Service
H Lundbeck AS - Key offerings
11.9 Mitsubishi Chemical Corp.
Mitsubishi Chemical Corp. - Overview
Mitsubishi Chemical Corp. - Business segments
Mitsubishi Chemical Corp. - Key offerings
Mitsubishi Chemical Corp. - Segment focus
11.10 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.11 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.12 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus

12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Indication - Market share 2023-2028 (%)
Exhibits31: Data Table on Indication - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Indication
Exhibits33: Data Table on Comparison by Indication
Exhibits34: Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Alzheimers disease - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Alzheimers disease - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Alzheimers disease - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Alzheimers disease - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Huntingtons disease - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Huntingtons disease - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Huntingtons disease - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Huntingtons disease - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Indication ($ million)
Exhibits55: Data Table on Market opportunity by Indication ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: AB Science SA - Overview
Exhibits110: AB Science SA - Product / Service
Exhibits111: AB Science SA - Key offerings
Exhibits112: AbbVie Inc. - Overview
Exhibits113: AbbVie Inc. - Product / Service
Exhibits114: AbbVie Inc. - Key news
Exhibits115: AbbVie Inc. - Key offerings
Exhibits116: Acadia Pharmaceuticals Inc. - Overview
Exhibits117: Acadia Pharmaceuticals Inc. - Product / Service
Exhibits118: Acadia Pharmaceuticals Inc. - Key offerings
Exhibits119: Biogen Inc. - Overview
Exhibits120: Biogen Inc. - Product / Service
Exhibits121: Biogen Inc. - Key news
Exhibits122: Biogen Inc. - Key offerings
Exhibits123: F. Hoffmann La Roche Ltd. - Overview
Exhibits124: F. Hoffmann La Roche Ltd. - Business segments
Exhibits125: F. Hoffmann La Roche Ltd. - Key news
Exhibits126: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits127: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits128: H Lundbeck AS - Overview
Exhibits129: H Lundbeck AS - Product / Service
Exhibits130: H Lundbeck AS - Key offerings
Exhibits131: Mitsubishi Chemical Corp. - Overview
Exhibits132: Mitsubishi Chemical Corp. - Business segments
Exhibits133: Mitsubishi Chemical Corp. - Key offerings
Exhibits134: Mitsubishi Chemical Corp. - Segment focus
Exhibits135: Novartis AG - Overview
Exhibits136: Novartis AG - Business segments
Exhibits137: Novartis AG - Key news
Exhibits138: Novartis AG - Key offerings
Exhibits139: Novartis AG - Segment focus
Exhibits140: Sanofi SA - Overview
Exhibits141: Sanofi SA - Business segments
Exhibits142: Sanofi SA - Key news
Exhibits143: Sanofi SA - Key offerings
Exhibits144: Sanofi SA - Segment focus
Exhibits145: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits146: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits147: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits148: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits149: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits150: Inclusions checklist
Exhibits151: Exclusions checklist
Exhibits152: Currency conversion rates for US$
Exhibits153: Research methodology
Exhibits154: Information sources
Exhibits155: Data validation
Exhibits156: Validation techniques employed for market sizing
Exhibits157: Data synthesis
Exhibits158: 360 degree market analysis
Exhibits159: List of abbreviations

この商品のレポートナンバー

0000039079

TOP